Perspectives in Lung Cancer is the first volume of Bentham Books new series, Frontiers in Lung Cancer. The new book, edited by Dr. Keyvan Moghissi et al., is a comprehensive compilation of basic and advanced topics on lung cancer pathology and treatment in a single volume. Chapters introduce the reader to chest and lung anatomy followed by the biology of lung cancer. Subsequent chapters delve into diagnostic methods for lung cancer while progressing into treatment options. Each chapter features contributions from experts in lung cancer treatment, thoracic surgery pulmonary disorders. The book culminates into an explanation of the concept of the Lung Cancer Centre, which is a representation of the editors' vision for organizing a lung cancer treatment unit.
The Editors' main goal is to give readers an updated view of current best practices in lung cancer clinics. "A book should have regard for the best care and treatment outcome of patients; I believe there is a vacuum within the currently available textbooks on lung cancer," says Dr. Moghissi.
Key features:
- Organises key topics covering both standard and avante-garde topics related to lung cancer
- All contributions are presented by experts in lung cancer treatment
- Addresses basic biology of lung cancer
- Provides information about 3D surgical planning, a relatively new concept in the field of thoracic surgery
- Addresses the standard method of resection, VATS and Mini VATS
- Covers the role of radiation and systemic anti-cancer therapies in lung cancer treatment
- Provides a glimpse of modern methods such as image guided surgery and therapy, laser therapy, and photodynamic therapy
- Covers the role of palliative care for lung cancer
- Presents information about a visionary organization of a lung cancer unit and treatment centre.
The combination of carefully organised chapters covering a wide array of interesting and relevant topics make this reference an essential reference for healthcare professionals interested in acquiring a broad perspective on lung cancer treatment with the goal of improving patient outcomes.
###
About The Editors:
Professor Keyvan Moghissi, BSc, MD, MS Chir, FRCS (Ed), FRCS (Eng) FETCS. In 1970 he was appointed Consultant in Cardio-thoracic Surgery.In 1982 he was honoured by receiving Membership of Academie Nationale de Chirurgie (Paris) and FRCS (England/ad Eundam). He is Clinical Director & Consultant Cardiothoracic Surgeon at the Yorkshire Laser Centre, UK and Honorary Consultant in Laser Surgery and Photodynamic Medicine at North East Lincolnshire & Goole Hospitals NHS Trust. Professor Moghissi has received many prizes for research and is Honorary member of numerous International Societies for Cardiothoracic Surgery. Amongst these honours is Outstanding Contribution and services to Cardiothoracic Surgery by the World Society of Cardiothoracic Surgery, and Visiting Professor of Guangzhou University in China. He has published a number of books and chapters in books in Cardiothoracic surgery, Laser and Photodynamic therapy with over 400 publications and presentations.
Doctor Jack Kastelik, MD, FRCP (UK) is Consultant in Respiratory and General Medicine at Hull University Teaching Hospitals, NHS Trust and Honorary Reader, University of Hull and Hull-York Medical school. He has a special interest in pleuro-pulmonary malignancies, and has a number of skills and qualifications in Postgraduate EducationTraining and Simulation.
He has published over 100 articles and Chapters in Lung Cancer and Respiratory Medicine. He is involved in the Respiratory Specialty Advisory Committee, British Thoracic Society Council, Educational and Professional and Organisational Standards committees and Regional Adviser for the Royal College of Physicians.
Doctor Philip Vernon Barber, FRCP is a Consultant Respiratory Physician, Manchester University Hospital Foundation Trust. He is Lung Cancer Lead Clinician, Macmillan Cancer Improvement PartnershipExpert Advisor to the NICE Centre for Clinical Practice. He led the Macmillan Cancer Improvement Partnership which in 2014 initiated the Manchester Lung Health Checks programme for the early detection of lung cancer in high-risk populations. He is a specialist adviser to the Nice Centre for Clinical Practice and a Board Director of the Medicines Evaluation Unit, winner of the Queen's Award for Enterprise in International Trade, 2020.
Peyman Sardari Nia MD, PhD is Senior Consultant Cardio-thoracic Surgeon in the department of cardio-thoracic surgery at Maastricht University Medical Center, the Netherlands; he specializes in minimally invasive cardio-thoracic surgery. He received his fellowship training in cardio-thoracic surgery at St Antonius Hospital in Nieuwegein, the Netherlands. He has received multiple awards for his research and innovations.He has published more than 50 peer-reviewed articles. He is an associate editor of European Journal of Cardio-Thoracic Surgery (EJCTS).
Keywords: lung cancer, pathology, diagnostic methods, thoracic surgery, pulmonary disorders, image guided surgery, palliative care, radiation
For further information, please visit: https://bit.ly/39qmfZ8